In this downloadable slideset, Emmanuel S. Antonarakis, MBBCh, reviews DNA repair deficiencies in prostate cancer and their therapeutic implications.
In this downloadable slideset, Heather H. Cheng, MD, PhD, examines practical challenges associated with genetic testing in advanced prostate cancer.
In this downloadable slideset, Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD, reviews the available clinical data on PARP inhibitors in advanced prostate cancer and explores how these agents may affect management strategies for patients in the near future.
In this on-demand Webcast of a CCO symposium at ASCO GU 2018, Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD; Emmanuel S. Antonarakis, MBBCh, and Heather H. Cheng, MD, PhD, review and discuss the latest data on DNA repair defects, genetic testing, and the use of PARP inhibitors in men with prostate cancer.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.